XML 53 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
Condensed Consolidated Statements of Cash Flows (USD $)
9 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Net income (loss) $ (2,333,967) $ (1,843,060)
Depreciation and amortization 10,995 17,400
Share-based compensation - stock options 138,630 67,639
Share-based consulting fees - common stock 35,000 17,800
Accrued stock contribution (directors stock expense)   7,717
(Gains) on sale of rental assets   (34,728)
Loss on disposal of property and equipment 4,817  
Unrealized loss on derivative instrument 24,317 17,361
(Increase) / Decrease in Receivables (124,501) (336,188)
(Increase) / Decrease in Due from factor   (465,000)
(Increase) / Decrease in Restricted cash 750,000  
(Increase) / Decrease in Prepaid expenses and other current assets 40,358 5,369
(Increase) / Decrease in Inventory (180,000) (2,500,227)
Increase / (Decrease) Accounts payable, accrued expenses and other liabilities 764,091 4,336,816
Net cash (used in) operating activities (870,260) (709,101)
Purchase of property and equipment (20,000) (14,685)
Proceeds from sale of rental asset   43,800
(Increase) / Decrease in security deposits 2,275 (2,275)
Net cash provided by (used in) provided by investing activities (17,725) 26,840
Proceeds from note payable 1,125,000 200,000
Repayment of note payable (265,000) (50,000)
Proceeds from exercise of stock options   10,050
Cash provided by financing activities 860,000 160,050
Net (decrease) in cash and cash equivalents (27,985) (522,211)
Cash and cash equivalents at beginning of period 28,485 557,018
Cash and cash equivalents at end of period 500 34,807
Cash paid for interest $ 4,559 $ 19,562